The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...
As the U.S. stock market navigates a period of volatility, with recent declines following the Federal Reserve's decision to maintain interest rates amid persistent inflation and awaiting major tech ...
The trial is anticipated to enrol 462 subjects and aims to confirm the safety and efficacy of the combination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback